KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Current Deferred Revenue (2020 - 2025)

Pfizer has reported Current Deferred Revenue over the past 6 years, most recently at $784.0 million for Q4 2025.

  • Quarterly Current Deferred Revenue fell 48.11% to $784.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $784.0 million through Dec 2025, down 48.11% year-over-year, with the annual reading at $784.0 million for FY2025, 48.11% down from the prior year.
  • Current Deferred Revenue was $784.0 million for Q4 2025 at Pfizer, down from $924.0 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $6.2 billion in Q4 2022 and troughed at $784.0 million in Q4 2025.
  • The 5-year median for Current Deferred Revenue is $2.4 billion (2023), against an average of $2.4 billion.
  • Year-over-year, Current Deferred Revenue surged 175.56% in 2021 and then plummeted 66.19% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $3.1 billion in 2021, then decreased by 17.84% to $2.5 billion in 2022, then grew by 7.14% to $2.7 billion in 2023, then plummeted by 44.04% to $1.5 billion in 2024, then crashed by 48.11% to $784.0 million in 2025.
  • Per Business Quant, the three most recent readings for PFE's Current Deferred Revenue are $784.0 million (Q4 2025), $924.0 million (Q3 2025), and $1.1 billion (Q2 2025).